glp-1 and parkinson's disease Beyond insulin: The Intriguing role of in GLP-1 Drugs and Parkinson's Disease:

[14] ( Figure 1A ) Approved in 2023, tirzepatide (TZP) is a dual GIP/GLP-1 receptor agonist that significantly enhances glycemic control and is under clinical investigation for obesity, cardiovascular disease, and non-alcoholic steatohepatitis

102 Most cases of favism result from ingestion of fresh beans

Marso SP, Daniels GH, Brown-Frandsen K et al (2016) Liraglutide and cardiovascular outcomes in type 2 diabetes

When I needed a receipt for FSA, it was readily available in my account

Robert Crayhon interviews with Stefan Siebrecht, PHD, and Salvatore Benvenga M.D

even though insulin sensitivity is improved when you're leaner, your genetics haven't changed, and if your hormonal blueprint leans more towards "carb sensitive" you'll still have to pay close attention to diet and exercise to stay insulin sensitive and subsequently, lean